Searchable abstracts of presentations at key conferences in endocrinology

ea0034p182 | Neoplasia, cancer and late effects | SFEBES2014

Pre-clinical assessment of the impact of Erlotinib on adrenocortical cancer cells proliferation

Dworakowska Dorota , Dudka Dorota , Weitsman Gregory , King Peter , Katugampola Harshini , Korbonits Marta , Schulte Klaus-Martin , Diaz-Cano Salvador , McGregor Alan , Grossman Ashley B , Aylwin Simon , Sworczak Krzysztof , Ng Tony

Introduction: Adrenocortical carcinoma (ACC) has a poor prognosis and limited therapeutic options. The epidermal growth factor receptor (EGFR) expression was found to be a good discriminator between malignant and benign adrenal tumours, but was mutated only in 3–10% of ACC cases.Aim: The aim of this study was to assess the effect of inhibition of EGFR with targeted therapies, i.e. Erlotinib (with and without EGF stimulation) on ACC cell proliferatio...

ea0034p232 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

High incidence of cardiac involvement in patients diagnosed with phaeochromocytoma: a clinical study using cardiovascular magnetic resonance imaging

Ferreira Vanessa , Rodrigues Mafalda , Piechnik Stefan , Marini Claudia , Karamitsos Theodoros , Francis Jane , Arnold Ranjit , Mihai Radu , Thomas Julia , Herincs Maria , Korbonits Marta , Hassan-Smith Zaki , Arlt Wiebke , Karavitaki Niki , Grossman Ashley , Neubauer Stefan , Wass John

Background: In patients with phaeochromocytoma, sudden and/or chronic exposure to catecholamines may predispose to cardiac pathology, including left ventricular (LV) hypertrophy, myocardial infarction, stress-induced cardiomyopathy and heart failure. We conducted the first prospective, multicentre study using cardiovascular magnetic resonance (CMR) imaging to describe the variety and incidence of cardiac abnormalities in phaeochromocytoma.Methods: Fifty ...

ea0070aep281 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The MAFA gene mutation responsible for familial insulinomatosis and diabetes impairs insulin secretion and results in downregulation of critical cell cycle regulators

Iacovazzo Donato , Thong Lim Chung , Quezado Rosana , Drummond Juliana , Antonio de Sousa Barros Fernando , Cuenco Joyceline , Brändle Michael , Walker Emily , Guo Min , Collier David , Khan Faraz , Wang Jun , Tan Tricia , Ellard Sian , Stein Roland , Korbonits Marta

The islet-enriched transcription factor MAFA regulates the expression of genes critical to beta cell function and insulin secretion. We previously described anovel MAFA mutation (c.191C > T, p.S64F) causing familial insulinomatosis and diabetes mellitus, with male carriers more often developing diabetes and females more prone to insulinomatosis. The exact molecular mechanisms underlying these phenotypes are unclear. In this study, we assessed glucose metabolism an...

ea0070aep600 | Pituitary and Neuroendocrinology | ECE2020

Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations

Marques Pedro , Magalhães Daniela , Caimari Francisca , Hernández Ramírez Laura , Collier David , Lim Chung , Stals Karen , Ellard Sian , Druce Maralyn , Akker Scott , Waterhouse Mona , Drake William , Grossman Ashley B. , Korbonits Marta

Introduction: Germline AIP and MEN1 mutations are the main known aetiologies of familial pituitary neuroendocrine tumours (PitNETs), which represent 5% of all PitNETs. We compared the clinical and tumour characteristics of AIP (AIP mut) and MEN1 mutation-positive (MEN1 mut) PitNET patients.Methods: We retrospectively analysed 70 MEN1 mut and 167 AIP mut patients with PitNETs. MEN...

ea0028p251 | Pituitary | SFEBES2012

The characterisation of growth hormone-related cardiac disease with magnetic resonance imaging

Thomas Julia , Dattani Abhishek , Burchell Thomas , Zemrak Filip , Khoo Bernard , Chew Shern , Kaplan Felicity , Drake William , Aylwin Simon , Gurnell Mark , Akker Scott , Petersen Steffen , Davies Ceri , Grossman Ashley , Korbonits Marta

Acromegaly causes a distinct cardiomyopathy. Growth hormone deficiency (GHD) limits cardiac response to exercise and increases cardiac mortality. Cardiac magnetic resonance imaging (CMR) is considered the gold standard for assessment of cardiac mass and provides data on function, fibrosis, valves and ischaemia. Twenty-three patients with abnormal GH levels (acromegaly, n=13; adult-onset GHD, n=10) and 23 matched controls underwent CMR. Patients had repeat CMR at ...

ea0021p210 | Endocrine tumours and neoplasia | SFEBES2009

Functional characterisation of aryl hydrocarbon receptor interacting protein (AIP) promoter and silent mutations

Igreja Susana , Chahal Harvinder , King Peter , Bolger Graeme , Srirangalingam Umasuthan , Guasti Leonardo , Chappel Paul , Gueorguiev Maria , Guegan Katie , Stals Karen , Khoo Bernard , Kumar Ajith , Ellard Sian , Grossman Ashley B , Korbonits Marta

AIP mutations predispose to familial isolated pituitary adenomas (FIPA) and 45 different AIP mutations have been described in the literature. Most of these mutations result in complete disruption of the C-terminal region of the AIP protein due to early stop codons. In this study we were particularly interested in the effect of AIP mutations in the promoter region (−270−−269CG & −220C) and 2 synonymous mutations (c.249G>T, p.G83= and c...

ea0016oc1.6 | Neuroendocrinology and pituitary | ECE2008

The metabolic effects of ghrelin and glucocorticoids are mediated by AMP-activated protein kinase (AMPK) and endogenous cannabinoids

Kola Blerina , Christ-Crain Mirjam , Farkas Imre , Wittmann Gabor , Lolli Francesca , Seboek Dalma , Harvey-White Judith , Kunos George , Muller Beat , Arnaldi Giorgio , Giacchetti Gilberta , Boscaro Marco , Grossman Ashley B , Fekete Csaba , Korbonits Marta

Ghrelin, cannabinoids and glucocorticoids have all orexigenic and widespread metabolic effects. AMPK is a major controller of many metabolic processes. We have studied the effects of ghrelin and glucocorticoids and their interaction with endocannabinoids using cannabinoid-receptor-1 (CB1) knock-out mice and CB1 antagonist-treated mice, and using tissue samples from patients with Cushing’s syndrome and from a rodent model of Cushing’s syndrome. AMPK activity and downs...

ea0015p192 | Endocrine tumours and neoplasia | SFEBES2008

AIP: a protein mutated in familial acromegaly plays a role in the regulation of cell proliferation and shows cell-type specific subcellular localisation

Leontiou Chrysanthia A , Gueorguiev Maria , Hassan Sevda , van der Spuy Jacqueline , Lolli Francesca , Stolbrink Maria , Christian Helen , Wray Jennifer , Bishop-Bailey David , Berney Dan M , Frohman Lawrence A , Chapple Paul J , Grossman Ashley B , Korbonits Marta

Mutations in AIP have been identified in a significant proportion of families with pituitary adenomas, most commonly in familial acromegaly. However, no data are available about the pituitary expression of AIP and how lack of AIP is involved in tumorigenesis.We identified 10 kindreds with AIP mutations out of 31 families. We studied RNA and protein expression of AIP in normal as well as familial and sporadic pituitary adenomas. In the normal pituitary st...

ea0014p211 | (1) | ECE2007

The metabolic changes induced by glucocorticoids: involvement of AMP-activated protein kinase

Christ-Crain Mirjam , Kola Blerina , Lolli Francesca , Fekete Csaba , Seboek Dalma , Wittman Gabor , Ajodha Sharon , Harvey-White Judith , Kunos George , Mueller Beat , Amaldi Giorgio , Giacchetti Gilberta , Boscaro Marco , Grossman Ashley , Korbonits Marta

Background: Excess glucocorticoids result in Cushing’s syndrome (CS) which is characterised by increased food intake, central obesity, dyslipidaemia and insulin resistance, leading to the metabolic syndrome. AMPK is a regulator of energy homeostasis and plays an important role in the regulation of appetite, glucose uptake, lipogenesis and gluconeogenesis. We hypothesised that the effects of corticosteroids on metabolism would be mediated by changes in AMPK activity in a t...

ea0013p166 | Diabetes, metabolism and cardiovascular | SFEBES2007

The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s Syndrome

Christ-Crain Mirjam , Kola Blerina , Lolli Francesca , Fekete Csaba , Seboek Dalma , Wittman Gabor , Ajodha Sharon , Harvey-White Judith , Kunos George , Mueller Beat , Amaldi Giorgio , Giacchetti Gilberta , Boscaro Marco , Grossman Ashley , Korbonits Marta

This abstract was printed as a duplication of abstract P291 and corrected onlineBackground: Excess glucocorticoids result in Cushing’s syndrome (CS) which is characterised by increased food intake, central obesity, dyslipidaemia and insulin resistance, leading to the metabolic syndrome. AMPK is a regulator of energy homeostasis and plays an important role in the regulation of appetite, glucose uptake, lipogenesis and gluconeogenesis. We hypothesised...